
1. obstet med. 2018 mar;11(1):23-27. doi: 10.1177/1753495x17731990. epub 2017 oct
25.

perinatal management hepatitis b virus: clinical implementation updated
australasian management guidelines.

bergin h(1)(2), wood g(2), walker sp(1)(2), hui l(1)(2).

author information: 
(1)department obstetrics gynaecology, university melbourne, melbourne, 
victoria, australia.
(2)2department perinatal medicine, mercy hospital women, melbourne,
victoria, australia.

objective: evaluate implementation 2013 royal australian new
zealand college obstetricians gynaecologists 'management hepatitis b in
pregnancy' guideline.
methods: retrospective cohort study clinical management obstetric
outcomes among hepatitis b virus-positive women single tertiary maternity
hospital. women viral load >200,000 iu/ml referred specialised
clinic consideration tenofovir disoproxil fumarate therapy reduce
mother child transmission.
results: total 11,496 women gave birth study period, 101
(0.9%) women hepatitis b virus positive. viral load measured 99 (98%)
of 101 hepatitis b virus-positive women; 30 (30%) viral load
>200,000 iu/ml. twenty-six women accepted tenofovir disoproxil fumarate; of
these, 23 successful virological response (viral load <200,000 iu/ml before
delivery).
conclusions: adherence updated management guidelines patient acceptance of
tenofovir disoproxil fumarate australian population high when
provided context dedicated perinatal service.

doi: 10.1177/1753495x17731990 
pmcid: pmc5888843
pmid: 29636810 

